Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion-Reference-Cited by-同舟云学术

Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion

Published:2010-04 Issue:4 Volume:394 Page:1042-1046
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Asaoka Yoshinari,Tada Motohisa,Ikenoue Tsuneo,Seto Motoko,Imai Mitsuho,Miyabayashi Koji,Yamamoto Keisuke,Yamamoto Shinzo,Kudo Yotaro,Mohri Dai,Isomura Yoshihiro,Ijichi Hideaki,Tateishi Keisuke,Kanai Fumihiko,Ogawa Seishi,Omata Masao,Koike Kazuhiko

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference24 articles.

1. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation;Marshall;Cell,1995

2. Tyrosine kinases and gastric cancer;Lin;Oncogene,2000

3. Cellular and molecular pathology of gastric carcinoma and precursor lesions: a critical review;Ming;Gastric Cancer,1998

4. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N. Engl. J. Med.,2004

5. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the development of hepatocyte growth factor/c-Met signaling pathway in gastric cancer: A review;World Journal of Gastrointestinal Oncology;2024-08-15

2. The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies;Frontiers in Pharmacology;2024-07-26

3. Ferroptosis regulating lipid peroxidation metabolism in the occurrence and development of gastric cancer;World Journal of Gastrointestinal Oncology;2024-06-15

4. Recording and classifying MET receptor mutations in cancers;eLife;2024-04-23

5. MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation;2023-11-05